In markets across Asia, Africa, Latin America, and parts of Eastern Europe where cold-chain infrastructure is unreliable, oral GLP-1s have the potential to unlock access to hundreds of millions of patients who could never have reliably received injectable therapy
Clinical studies have shown that patients taking oral semaglutide achieved significant weight reduction over periods of up to 68 weeks
It's the treatment that's most appropriate for your individual needs after a discussion with your healthcare provider
Support patients in navigating their dietary preferences and maintaining adequate intake
As for the rate of weight loss, Siegel says, With all of these medications, this is where its important to have a discussion with your provider on your progress
days First visible results appear within two weeks